129 related articles for article (PubMed ID: 14634801)
1. Immunohistochemical determination of HER-2/neu, c-Kit (CD117), and vascular endothelial growth factor (VEGF) overexpression in malignant melanoma.
Potti A; Moazzam N; Langness E; Sholes K; Tendulkar K; Koch M; Kargas S
J Cancer Res Clin Oncol; 2004 Feb; 130(2):80-6. PubMed ID: 14634801
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical determination of HER-2/neu overexpression in malignant melanoma reveals no prognostic value, while c-Kit (CD117) overexpression exhibits potential therapeutic implications.
Potti A; Hille RC; Koch M
J Carcinog; 2003 Nov; 2(1):8. PubMed ID: 14617373
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of HER-2/neu, c-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas.
Potti A; Ganti AK; Foster H; Knox S; Hebert BJ; Tendulkar K; Sholes K; Koch M; Kargas S
Anticancer Res; 2004; 24(1):333-7. PubMed ID: 15015617
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical identification of HER-2/neu overexpression and CD117 (c-kit) expression in multiple myeloma.
Potti A; Ganti AK; Koch M; Levitt R; Mehdi SA
Leuk Lymphoma; 2002 Dec; 43(12):2427-30. PubMed ID: 12613538
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.
Youssef NS; Said AM
Int J Clin Exp Pathol; 2014; 7(9):5725-37. PubMed ID: 25337214
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical determination of vascular endothelial growth factor (VEGF) overexpression in malignant melanoma.
Potti A; Moazzam N; Tendulkar K; Javed NA; Koch M; Kargas S
Anticancer Res; 2003; 23(5A):4023-6. PubMed ID: 14666713
[TBL] [Abstract][Full Text] [Related]
7. mTOR, VEGF, PDGFR, and c-kit signaling pathway activation in Kaposi sarcoma.
Kerr DA; Busarla SVP; Gimbel DC; Sohani AR; Nazarian RM
Hum Pathol; 2017 Jul; 65():157-165. PubMed ID: 28506734
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Her-2/NEU in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating NF-kappa B: implications for malignant ascites formation and tumor lymphangiogenesis.
Hsieh CY; Chen CA; Chou CH; Lai KP; Jeng YM; Kuo ML; Wei LH
J Biomed Sci; 2004; 11(2):249-59. PubMed ID: 14966375
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of C-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in mantle cell lymphoma.
Potti A; Ganti AK; Kargas S; Koch M
Anticancer Res; 2002; 22(5):2899-901. PubMed ID: 12530014
[TBL] [Abstract][Full Text] [Related]
10. Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients.
Konecny GE; Meng YG; Untch M; Wang HJ; Bauerfeind I; Epstein M; Stieber P; Vernes JM; Gutierrez J; Hong K; Beryt M; Hepp H; Slamon DJ; Pegram MD
Clin Cancer Res; 2004 Mar; 10(5):1706-16. PubMed ID: 15014023
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical determination of HER-2/neu in malignant melanoma.
Potti A; Hille R; Koch M
Anticancer Res; 2003; 23(5A):4067-9. PubMed ID: 14666720
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic value of putative cancer stem cell markers CD117 and CD15 in choroidal and ciliary body melanoma.
Lukenda A; Dotlic S; Vukojevic N; Saric B; Vranic S; Zarkovic K
J Clin Pathol; 2016 Mar; 69(3):234-9. PubMed ID: 26290260
[TBL] [Abstract][Full Text] [Related]
13. Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma.
Brunner M; Thurnher D; Pammer J; Geleff S; Heiduschka G; Reinisch CM; Petzelbauer P; Erovic BM
Mod Pathol; 2008 Jul; 21(7):876-84. PubMed ID: 18408656
[TBL] [Abstract][Full Text] [Related]
14. Relationship of endothelial area with VEGF-A, COX-2, maspin, c-KIT, and DOG-1 immunoreactivity in liposarcomas versus non-lipomatous soft tissue tumors.
Jung I; Gurzu S; Turdean S; Ciortea D; Sahlean DI; Golea M; Bara T
Int J Clin Exp Pathol; 2015; 8(2):1776-82. PubMed ID: 25973067
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas.
Li Q; Wang D; Li J; Chen P
BMC Cancer; 2011 Jun; 11():277. PubMed ID: 21708009
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Kostopoulos I; Arapantoni-Dadioti P; Gogas H; Papadopoulos S; Malamou-Mitsi V; Scopa CD; Markaki S; Karagianni E; Kyriakou V; Margariti A; Kyrkou E; Pavlakis K; Zaramboukas T; Skordalaki A; Bourli A; Markopoulos C; Pectasides D; Dimopoulos MA; Skarlos D; Fountzilas G
Breast Cancer Res Treat; 2006 Apr; 96(3):251-61. PubMed ID: 16538542
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
Massard C; Voigt JJ; Laplanche A; Culine S; Lortholary A; Bugat R; Theodore C; Priou F; Kaminsky MC; Lesimple T; Pivot X; Coudert B; Douillard JY; Merrouche Y; Fizazi K
Br J Cancer; 2007 Oct; 97(7):857-61. PubMed ID: 17876336
[TBL] [Abstract][Full Text] [Related]
18. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.
Perrone G; Santini D; Vincenzi B; Zagami M; La Cesa A; Bianchi A; Altomare V; Primavera A; Battista C; Vetrani A; Tonini G; Rabitti C
Histopathology; 2005 May; 46(5):561-8. PubMed ID: 15842638
[TBL] [Abstract][Full Text] [Related]
19. HER-2/neu and CD117 (C-kit) overexpression in hepatocellular and pancreatic carcinoma.
Potti A; Ganti AK; Tendulkar K; Chitajallu S; Sholes K; Koch M; Kargas S
Anticancer Res; 2003; 23(3B):2671-4. PubMed ID: 12894556
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]